About Lifeline Pharmaceutical Private Limited
Data last updated:
Lifeline Pharmaceutical Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Keimed Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 October 2018.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TS2018PTC174776. Its GSTIN is 07AADCL7537R1ZR (Delhi).
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was led by directors Shyam Sunder Kathuria and Arvind Kumar Venkat.
Its last annual general meeting (AGM) was held on 09 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹95.67 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net loss of ₹1.14 Cr (net margin -1.2%) and EBITDA of ₹1.93 Cr (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
The company was associated with 2 brands: Lifeline Pharmaceuticals and Neelkanth Drugs. As per MCA filings, the company had satisfied charges of ₹20 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹9.4 Cr; the latest was in March 2020. Its 10 peer companies in the same principal business activity (retail trading) are compared by revenue, 5 larger and 5 smaller; the largest is Banerjee Automobiles Private Limited with revenue of ₹96.01 Cr.
The last known website on record is neelkanthdrugs.in.
Company details
CIN history
Lifeline Pharmaceutical has one previous CIN (Corporate Identification Number): U51909DL2018PTC341312. The current CIN is U51909TS2018PTC174776, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909TS2018PTC174776 | Current |
| U51909DL2018PTC341312 | Previous |
Contact details
Lifeline Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana. Its website is neelkanthdrugs.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Apps
- Registered AddressD.No 7 – 2 – 1740 K Subbaiah Pillai, Godowns Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lifeline Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lifeline Pharmaceutical operates two associated brands: Lifeline Pharmaceuticals and Neelkanth Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Wholesale distributor of branded, generic, and specialty drugs with nationwide delivery. | lifelinepharm.com | |
| Distributes pharmaceuticals, vaccines, and wellness products across North India via efficient network. | neelkanthdrugs.in |
Business activity
The main business activity of Lifeline Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Lifeline Pharmaceutical Private Limited, buy the company report.
Financials of Lifeline Pharmaceutical Private Limited
FY 2023 filings availableLifeline Pharmaceutical Private Limited reported revenue of ₹95.67 Cr (up 13% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 13% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹95.67 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.14 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lifeline Pharmaceutical Private Limited, buy the company report.
Board of directors of Lifeline Pharmaceutical Private Limited
Lifeline Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 07 Feb 2019 | 7 Years 8 Months | As last reported |
| Shyam Sunder Kathuria Also directs: Lifeline Pharma Distributors Private Limited | Director | 30 Oct 2018 | 7 Years 11 Months | As last reported |
Peer comparison
Lifeline Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Banerjee Automobiles Private Limited | ₹96.01 Cr (FY 2024) | -2.0% | Durgapur, West Bengal, India | |||
| Fortune Malayalam Vehicles Private Limited | ₹95.97 Cr (FY 2025) | 8.0% | Hyderabad, Telangana, India | |||
| Amrut Sanjivani Sugarcane Private Limited | ₹95.87 Cr (FY 2024) | 42.0% | Ahmednagar, Maharashtra, India | |||
| Ashvita Fine Art & Collectibles Private Limited | ₹95.87 Cr (FY 2024) | 206.0% | Chennai, Tamil Nadu, India | |||
| VBSS Overseas Private Limited | ₹95.71 Cr (FY 2016) | 127.0% | New Delhi, Delhi, India | |||
| Lifeline Pharmaceutical Private Limitedthis company | ₹95.67 Cr (FY 2023) | -₹1.14 Cr | -1.2% | 13.0% | Hyderabad, Telangana, India | |
| Zel Jewellers Limited | ₹95.65 Cr (FY 2025) | 21.0% | New Delhi, Delhi, India | |||
| Prompt Data Products Pvt Ltd | ₹95.52 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Vesara Jewels Private Limited | ₹95.33 Cr (FY 2025) | 24.0% | Bangalore, Karnataka, India | |||
| Agro Wheels Marketing Private Limited | ₹95.32 Cr (FY 2025) | 103.0% | Alwar, Rajasthan, India | |||
| Shankar Electricals Services (I) Private Limited | ₹95.23 Cr (FY 2022) | 110.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Lifeline Pharmaceutical Private Limited, buy the company report.
Auditor
Lifeline Pharmaceutical Private Limited is audited by KOHLI GARG & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KOHLI GARG & ASSOCIATES | FY 2023 | 023606N |
Shareholding
The shareholding of Lifeline Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lifeline Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2020 | 100347431 | Hdfc Bank Limited | ₹12 Cr | Satisfied | |
| 26 Apr 2019 | 100262478 | Others | ₹8 Cr | Satisfied |
To see the full charge records of Lifeline Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Lifeline Pharmaceutical Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹9.4 Cr; the latest was in March 2020.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Lucky Pharmaceuticals Private Limited Seller: Keimed Private Limited |
| Mar 2019 | Funding round | ₹9.26 Cr | Investors: Keimed Private Limited , Neelkanth Drugs Private Limited , Lucky Pharmaceuticals Private Limited |
| Dec 2018 | Funding round | ₹14 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Lifeline Pharmaceutical Private Limited has 3 court cases on record: 3 filed by Lifeline Pharmaceutical. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed by the company against M/S the Surge Distributors | Disposed |
To see the full case history of Lifeline Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Lifeline Pharmaceutical Private Limited was last rated by Care on 16 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 16 Dec 2020 |
To see the full credit ratings and regulatory alerts of Lifeline Pharmaceutical Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lifeline Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lifeline Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCL7537R1ZR | Delhi | Active | 05 Nov 2018 |
To see the full GST registrations and return filing status of Lifeline Pharmaceutical Private Limited, buy the company report.
Recent activity
Lifeline Pharmaceutical Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Arvind Kumar Venkat ceased to be Additional Director on 20 Jul 2019.
Frequently asked questions
Lifeline Pharmaceutical has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Lifeline Pharmaceutical was a private limited company based in Hyderabad, Telangana, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 October 2018 and is registered under CIN U51909TS2018PTC174776. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Lifeline Pharmaceutical was incorporated on 30 October 2018. It is registered with the Registrar of Companies, Hyderabad.
Lifeline Pharmaceutical had 2 directors:
- Arvind Kumar Venkat - Nominee Director
- Shyam Sunder Kathuria - Director
The CIN (Corporate Identification Number) of Lifeline Pharmaceutical is U51909TS2018PTC174776. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Lifeline Pharmaceutical is at D.No 7 – 2 – 1740 K Subbaiah Pillai, Godowns Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018.
Lifeline Pharmaceutical can be reached through the website neelkanthdrugs.in. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Lifeline Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 09 August 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Lifeline Pharmaceutical is 07AADCL7537R1ZR, registered in Delhi.
Lifeline Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
Lifeline Pharmaceutical has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹9.4 Cr; the latest was in March 2020.